Poly Medicure Limited , a prominent player in the medical devices industry, has taken a significant step towards transparency by making available the audio recording of a recent analyst and investor conference call. The call, which took place on September 4, 2025, at 4:00 PM Indian time, focused on the company's proposed acquisition of the PendraCare Group.

Key Highlights

• Conference Call Details: The call was held on September 4, 2025, at 4:00 PM Indian time.
• Topic of Discussion: The proposed acquisition of PendraCare Group.
• Accessibility: The audio recording is now available on Poly Medicure's official website.
• Regulatory Compliance: This move aligns with the company's commitment to meeting regulatory requirements.

Acquisition Details

According to the LODR (Listing Obligations and Disclosure Requirements) data, Poly Medicure has entered into a Share Purchase Agreement (SPA) through its wholly-owned step-down subsidiary, RisoR Holdings B.V., based in Amsterdam, Netherlands. The agreement is with Wellinq Holdings B.V., also located in Amsterdam, Netherlands.

Key Points of the Acquisition

• Target Companies: The acquisition involves Pendracare Holdings B.V. and Wellinq Medical B.V., collectively referred to as the "PendraCare Group".
• Ownership Structure: Post-acquisition, Poly Medicure Limited, through RisoR Holding B.V., will own 90% of the economic rights in the PendraCare Group.
• Strategic Move: This acquisition is expected to strengthen Poly Medicure's position in the medical devices sector.

Implications for Investors

The release of the conference call audio recording demonstrates Poly Medicure's commitment to keeping its investors and analysts well-informed about significant corporate actions. This level of transparency is particularly crucial given the scale and potential impact of the PendraCare Group acquisition on the company's future operations and market position.

Regulatory Compliance

The company has emphasized that the audio recording's release is in compliance with Regulation 30 and 46(2)(oa) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. This adherence to regulatory standards underscores Poly Medicure's dedication to maintaining good corporate governance practices.

Conclusion

As Poly Medicure Limited moves forward with its acquisition plans, the availability of the conference call recording provides stakeholders with valuable insights into the company's strategic direction. Investors and analysts are encouraged to access the recording on the company's website for a comprehensive understanding of the proposed PendraCare Group acquisition and its potential implications for Poly Medicure's future growth trajectory.

Poly Medicure Limited , a prominent player in the medical devices industry, has made a significant move to strengthen its international presence and expand its product portfolio. The company has incorporated a wholly owned step-down subsidiary in the Netherlands, setting the stage for a strategic acquisition in the European medical devices market.

Key Developments

Incorporation of RisoR Holdings B.V.

• Poly Medicure has established RisoR Holdings B.V. as a wholly owned step-down subsidiary in Amsterdam, Netherlands.
• The new entity was incorporated on August 29, with an aggregate issued capital of EUR 9.00.
• RisoR Holdings B.V. is directly owned by Poly Medicure B.V., which is a wholly owned subsidiary of Poly Medicure Limited.

Acquisition of PendraCare Group

• RisoR Holdings B.V. has been approved to enter into a Share Purchase Agreement (SPA) with Welling Holdings B.V., Netherlands.
• The purpose of this agreement is to acquire ordinary shares of Pendracare Holdings B.V. and Welling Medical B.V., collectively known as the "PendraCare Group".
• Upon completion of the acquisition, Poly Medicure Limited, through RisoR Holdings B.V., will own 90% of the economic rights in the PendraCare Group.

Strategic Implications

This move by Poly Medicure demonstrates the company's commitment to expanding its global footprint and enhancing its product offerings. The acquisition of a majority stake in the PendraCare Group is likely to provide Poly Medicure with:

• Access to new markets in Europe
• Potential synergies in research and development
• Expansion of its product portfolio in the medical devices sector

Corporate Structure

The corporate structure following these developments will be as follows:

1. Poly Medicure Limited (Parent Company)
2. Poly Medicure B.V. (Wholly owned subsidiary of Poly Medicure Limited)
3. RisoR Holdings B.V. (Wholly owned subsidiary of Poly Medicure B.V.)
4. PendraCare Group (90% economic rights owned by RisoR Holdings B.V. post-acquisition)

Regulatory Compliance

The company has stated that these actions are in compliance with Regulation 30 and 33 of SEBI (LODR) Regulations, 2015. The Board of Directors approved these developments in a meeting held on September 3.

Poly Medicure has committed to providing further details as required under SEBI regulations upon signing and entering into the Shareholders Agreement (SHA) related to this acquisition.

As the medical devices industry continues to evolve globally, Poly Medicure's strategic moves position it to capitalize on international opportunities and potentially enhance its competitive edge in the market.